This company listing is no longer active
Signify Health Past Earnings Performance
Past criteria checks 5/6
Key information
-53.1%
Earnings growth rate
71.4%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 18.3% |
| Return on equity | -15.9% |
| Net Margin | 9.5% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
CVS Health to offer bonds to finance purchase of Signify Health
Feb 13Signify Health and Prospect Medical come together to deliver coordinated, high-quality care
Jan 11Checking Signify Health Before The CVS Transaction
Dec 21Signify expands diagnostic offering with spirometry test for lung disease
Oct 18Signify Health jumps on report CVS in talks to acquire for about $8 billion
Sep 02Signify Health: Cathie Wood Now Selling
Aug 15CVS Health seeking purchase of Signify Health - WSJ
Aug 07Signify Health: ECS Wind Down Sheds Light On Compelling Valuation
Jul 21Signify Health Aims Higher With New CMS Terms
Mar 16Revisiting Signify Health
Jan 09Signify Health names Susan Yun as chief people officer
Jun 02Revenue & Expenses Breakdown
How Signify Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 806 | 77 | 233 | 0 |
| 30 Sep 22 | 784 | -518 | 285 | 0 |
| 30 Jun 22 | 843 | -338 | 275 | 0 |
| 31 Mar 22 | 810 | 32 | 258 | 0 |
| 31 Dec 21 | 653 | 43 | 174 | 0 |
| 30 Sep 21 | 786 | -3 | 245 | 0 |
| 30 Jun 21 | 741 | -23 | 230 | 0 |
| 31 Mar 21 | 659 | -23 | 214 | 0 |
| 31 Dec 20 | 451 | -25 | 145 | 0 |
| 30 Sep 20 | 550 | -8 | 198 | 0 |
| 31 Dec 19 | 502 | 0 | 168 | 0 |
| 31 Dec 18 | 338 | -29 | 67 | 0 |
Quality Earnings: SGFY has high quality earnings.
Growing Profit Margin: SGFY's current net profit margins (9.5%) are higher than last year (6.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SGFY has become profitable over the past 5 years, growing earnings by -53.1% per year.
Accelerating Growth: SGFY's earnings growth over the past year (79.2%) exceeds its 5-year average (-53.1% per year).
Earnings vs Industry: SGFY earnings growth over the past year (79.2%) exceeded the Healthcare industry -12.4%.
Return on Equity
High ROE: SGFY's Return on Equity (-15.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/03/30 08:29 |
| End of Day Share Price | 2023/03/28 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Signify Health, Inc. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Steven Valiquette | Barclays |
| Sarah James | Barclays |